Category: Health

  • Sajid Javid – 2022 Statement at the Alzheimer’s Society Conference

    Sajid Javid – 2022 Statement at the Alzheimer’s Society Conference

    The statement made by Sajid Javid, the Secretary of State for Health and Social Care, on 17 May 2022.

    Thank you Gina – not just for your warm introduction, but for everything you do, raising awareness and supporting other people living with dementia. Thank you very much.

    And I’m also grateful to the Alzheimer’s Society for bringing us all together this afternoon.

    I can’t begin to reflect on what the future holds without acknowledging the challenges of the past two years. Whether it’s the people living with dementia, or those around them who love and care for them, I know dementia is difficult at the best of times. The pandemic made it doubly difficult.

    Dementia made some of the steps we needed to take to combat the pandemic a lot harder: like extra handwashing, or socially distancing. Or families and carers, who had very little respite.

    But I know it’s the emotional side that’s proved toughest over time. It runs deeper than the smiles and hugs we all missed.

    Many of you have tirelessly smashed the taboos around dementia – like the idea dementia is a hidden disease. Lots of you – people like Gina – are proof that people with dementia shouldn’t be hidden away from society.

    But sadly, the pandemic saw us all spend more time behind closed doors, physically separated from society and the people that we love.

    So I want to say a huge thank you to all of you, for your tremendous courage and resilience in the most extraordinary of circumstances.

    When I accepted this role nearly a year ago, I made it my priority to safely remove so many of the restrictions around Covid. Burdens that kept us apart through these difficult times. We’re now leading the world in learning to live with Covid, and I’m proud of how far we’ve come.

    Yet even with these brighter days ahead, I know it will take some time for us to recover from this collective trauma. And, of course, the challenges of conditions like dementia haven’t gone away.

    Over 900,000 people in the UK are believed to be living with dementia. In 2020, it was the leading cause of death (in England and Wales) after Covid-19.

    Yet even when we’re faced with such stark statistics, it’s important to remember how we got here.

    Economic growth, medical breakthroughs and vastly improved health and care services have seen life expectancy increase by more than a decade in our lifetimes. It’s one of the great triumphs of the 20th Century. We’re all living longer.

    If we’re to get the 21st Century right, we need those extra years to be spent in good health.

    And sadly that’s not the case for too many people. By 2025, 1 million people in the UK are expected to have dementia, and is expected to rise to 1.6 million by 2040.

    There has been some great progress in recent years.

    David Cameron used the rotating chairmanship of the G8 to convene the world’s first G8 dementia summit – which took the dementia challenge onto the global stage. And that passion for global action against dementia has continued in his current role as President of Alzheimer’s Research UK.

    And I do want to pay tribute to David, because I remember very well when I was in his Cabinet: he dedicated an entire cabinet session to dementia and invited Alzheimer’s UK to speak to us. They enrolled us all as ‘dementia friends’, and even all these years later now I’m Health and Social Care Secretary, I still reflect on what I learned back then.

    The Challenge on Dementia 2020 was another landmark piece of work, which saw a million care workers and a million NHS workers receive dementia awareness training. Over the 5 years of the strategy, the government invested some £420 million on dementia research.

    But the pandemic has stemmed the tide of progress. Despite the best efforts of the NHS, it became harder for some people to get a timely diagnosis, because the pandemic made it more difficult to access memory assessment services. I know the Alzheimer’s Society has estimated over 30,000 people didn’t receive a diagnosis because of the pandemic.

    Equally, we know from your brilliant research that tens of thousands of people are still missing out on a dementia diagnosis each year because they confuse key symptoms with getting old. As you say: “It’s not called getting old, it’s called getting ill”.

    So, while these broader demographic trends, combined with the rising prevalence of dementia, were always going to take us to a crossroads – a moment where we’d have to rethink how we do health and care in this country – the pandemic has brought us to these crossroads a lot more quickly. In fact, we’re there right now.

    I think one of the reasons why we haven’t made as much progress on dementia as we would like is because it’s going to take some pretty seismic shifts, both in terms of the architecture of health and care and our own approach.

    That’s hard to do. Reform takes time. And you need to take people with you. But it’s a journey we’ve already begun – and it’s a challenge this government is unafraid to take on.

    Our plans for Adult Social Care will help improve experiences for people with dementia and their families: with a far more generous means-testing, a cap on life-time costs to increase support and development for our phenomenal workforce.

    The new Health and Care Act – which received Royal Assent just a couple of weeks ago – puts Integrated Care Boards and Integrated Care Partnerships at the heart of our system. Joint working and joint budgets will be directed towards caring for people and keeping them well in the first place.

    You may also know that we asked Claire Fuller – a GP and Chief Executive of Surrey Heartlands – to conduct a stocktake of how primary care works within the new system. Now this is important, because we know that primary care is where the bulk of prevention can happen – and GPs play a crucial role in referring people with early signs of dementia. So I’m looking forward to hearing Dr Fuller’s views.

    We know that joined up care is better for people with dementia and their families. Implementing the proposals in our Integration White Paper will be another important part of what we need to do. The White Paper looks at everything from better data-sharing to multidisciplinary working across health and care, with the ambition of improving the experiences of those who use our vital services.

    All of this taken together means our future work on dementia is going to take place in a very different health and care context – one which is much more preventive, professional, and joined up.

    Not only that, but the combination of the demographic shifts we all know are coming, the setbacks of Covid-19, and the incredible opportunities afforded to us by pioneering research and new technology, mean we now need to do something dramatically different. We have no other choice but to step up and rise to this moment.

    So that’s been the spirit behind our new dementia strategy, which we began developing last summer. I’m grateful to everyone who’s played a part and continues to play a part in bringing it to life, including the Alzheimer’s Society. That work is still ongoing, but today I want to tell you a bit more about what it will look like.

    In short, I want it to be more ambitious than anything we’ve done before. To begin with: I want our Dementia Strategy to be a 10-year plan, not just 5. Because we can only get to grips with long-term challenges by thinking long-term.

    I’d like us to be as bold as we’ve been with our 10-year plan for cancer. It will be driven by the same four themes behind our reforms in health and care – what I call the ‘four P’s’: prevention, personalisation, performance and people.

    Let’s look at prevention for a moment.

    It’s estimated that as much as 40 percent of dementia is potentially preventable. 40 percent.

    We now know that what’s good for the heart is also good for the brain. Action on high blood pressure, physical inactivity, alcohol, obesity and healthy eating all have a part to play.

    So we’re going to be very ambitious on prevention, because I don’t accept that dementia is an inevitable part of ageing. It isn’t.

    We’re going to be equally ambitious on research.

    We’ve already committed £375 million into research on neurodegenerative diseases over the next five years – and I’ll work across government to boost this further.

    It means measuring ourselves against the leading countries globally and being unafraid to find new ways of working. It means being bold about finding new medicines and new treatments. It means being ambitious on new technology, like genomic sequencing and digital biomarkers. And it means continuing to smash taboos – just as you do so brilliantly, every single day.

    So I’m really excited about this – and I’m excited to work with all of you get it right. Because it’s no exaggeration to say that our future depends on it.

    We’re at the crossroads. All of us here today, we understand the challenges that lie ahead. When it comes to dementia, we know there have never been any quick fixes. We know there aren’t any easy wins.

    But we also know that when a visionary plan comes together, with powerful partners and proper funding – and we couple it with care and compassion – that combination can be unbeatable.

    That’s going to be the mission – and I’m grateful to have partners like you to share it with. Thank you.

     

  • Maggie Throup – 2022 Statement on the Delay in Volume Price Promotion and Advertising Restrictions

    Maggie Throup – 2022 Statement on the Delay in Volume Price Promotion and Advertising Restrictions

    The statement made by Maggie Throup, the Parliamentary Under-Secretary of State for Health and Social Care, in the House of Commons on 16 May 2022.

    The Government are delaying the implementation of the volume price promotion restrictions and the introduction of further advertising restrictions on TV and online for high fat, sugar or salt (HFSS) products by 12 months.

    We are clear that the delay to volume price promotions does not impact the locations measures which will still come into force on 1 October 2022. Under these measures, less healthy products in scope will no longer be promoted in key locations, such as checkouts, store entrances, aisle ends and their online equivalents. We expect these location restrictions to be the single most impactful obesity policy at reducing children’s calorie consumption and are expected to accrue health benefits of over £57 billion and provide NHS savings of over £4 billion, over the next 25 years.

    The delay to restrictions on multibuy deals will allow the Government to review and monitor the impact of the restrictions on the cost of living in light of an unprecedented global economic situation.

    A delay to the advertising restrictions is necessary because a delay in the Health and Care Act 2022 receiving Royal Assent has had a consequential impact on the timetable for the regulators’ subsequent consultations and publication of final guidance, meaning it was unlikely this would be ready with sufficient time before implementation.

    We have also considered the ongoing concerns from industry about having time to fully implement the final guidance, by restructuring their funding and revenue streams appropriately, and ensuring robust compliance from implementation. We therefore believe this is the best approach to balance tackling childhood obesity in a timely way, managing the unprecedented economic situation and ensuring the smooth and effective implementation of these restrictions. The advertising regulations will now come into force on 1 January 2024.

    We included a power in the Health and Care Act to delay implementation of the advertising restrictions if necessary. We will be utilising this power to amend the date of implementation for the advertising restrictions by secondary legislation. The implementation of the volume price restrictions will also be amended by secondary legislation.

    This Government remain committed to halving childhood obesity by 2030 and these measures and others, including last month’s new measures on calorie labelling in large restaurants, cafes and takeaways, will play their part in delivering against this ambition.

  • Sajid Javid – 2022 Comments on Freezing Prescription Charges

    Sajid Javid – 2022 Comments on Freezing Prescription Charges

    The comments made by Sajid Javid, the Secretary of State for Health and Social Care, on 15 May 2022.

    The rise in the cost of living has been unavoidable as we face global challenges and the repercussions of Putin’s illegal war in Ukraine. Whilst we can’t completely prevent these rises, where we can help – we absolutely will. This is why I am freezing prescription charges to help ease some of these pressures and put money back in people’s pockets.

  • Julia Lopez – 2022 Comments on Delay to Ban Multibuy Deals

    Julia Lopez – 2022 Comments on Delay to Ban Multibuy Deals

    The comments made by Julia Lopez, the Media, Data and Digital Minister, on 14 May 2022.

    We are determined to tackle childhood obesity and are working hard to improve young people’s health, including by investing £550 million of government and lottery cash to level up access to sport and physical activity right across the country

    We have listened to the concerns which have been raised and will not be bringing in restrictions on junk food advertising until confident that the time is right.

  • Sajid Javid – 2022 Statement on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    Sajid Javid – 2022 Statement on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

    The statement made by Sajid Javid, the Secretary of State for Health and Social Care, in the House of Commons on 12 May 2022.

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects the lives of children and adults across the country. It can be an incredibly disabling condition with fluctuating symptoms, making it difficult to take part in everyday activities, enjoy a family or social life, access services and engage in work or education, especially for the estimated 25% of people who have severe or very severe symptoms. Whilst there are currently no known cures or treatments for the condition, people with ME/CFS can be supported to manage their symptoms and maximise their quality of life.

    Today, on World ME Day, I have two announcements to make to show that the Government are committed to better care and support for people living with ME/CFS and their families.

    Firstly, I am pleased to welcome today the publication of the top 10 (plus) research priorities for ME/CFS, published by Action for ME and agreed by the James Lind Alliance Priority Setting Partnership on ME. This partnership included people with lived experience and clinicians working together to reach a consensus. I want to thank Action for ME and everyone who took part in this important work, recognising that for many this would have taken considerable effort.

    To support these research priorities, I will co-chair a roundtable with my Department’s chief scientific adviser, Professor Lucy Chappell, to bring together experts on ME/CFS, including people with lived experience, to discuss what needs to happen next. The chief scientific adviser has asked the UK clinical research collaboration to convene a subgroup on ME/CFS to work with funders, researchers, charities, and people with ME/CFS to drive high-quality applications for research into ME/CFS and support the research community to build capacity and capability in this field. We are committed to funding research into this important area. Funding for high-quality research into ME is available through existing commitments of HM Government to research and development. The National Institute for Health and Care Research (NIHR) will work with the research community to respond to the priorities as set out in the Priority Setting Partnership, alongside other funding partners.

    Secondly, I am announcing the Government intention to develop a cross-Government delivery plan on ME/CFS for England, aligning with other devolved nations as appropriate. In particular, we are engaging with the Scottish Government to explore areas of potential shared interest and learning, especially in terms of research into ME/CFS.

    This will build on the recommendations of the priority setting partnership, the recently updated guideline for ME/CFS from the National Institute for Health and Care Excellence, and the comprehensive work of the All-Party Parliamentary Group on Myalgic Encephalomyelitis to date.

    At the heart of the delivery plan will be two core principles: firstly, that we do not know enough about ME/CFS, which must change if we are to improve experiences and outcomes; secondly, we must trust and listen to those with lived experience of ME/CFS.

    Following this announcement, officials will work with stakeholders ahead of publishing the delivery plan later this year.

  • Gillian Keegan – 2022 Comments on Increased Mental Health Support for Children

    Gillian Keegan – 2022 Comments on Increased Mental Health Support for Children

    The comments made by Gillian Keegan, the Minister for Mental Health, on 12 May 2022.

    The last two years have been particularly challenging and although children are incredibly resilient, it’s crucial they can access mental health support as early as possible.

    We’re making great progress on better supporting young people’s mental health and this additional funding to train senior mental health leads will complement our work on the accelerated rollout of Mental Health Support Teams in schools and expansion of community services which is well underway.

    We have recently opened a call for evidence and I encourage people of all ages to share their views to inform a new 10-year mental health plan to keep the nation in positive mental wellbeing.

  • Colm Gildernew – 2022 Comments on the Needs of Cancer Patients in Northern Ireland

    Colm Gildernew – 2022 Comments on the Needs of Cancer Patients in Northern Ireland

    The comments made by Colm Gildernew, the Sinn Fein MLA for Fermanagh and South Tyrone, on 10 May 2022.

    People on cancer waiting lists need an Executive back up and running now.

    Macmillan Cancer Support has said today that 82,000 people in the north are currently living with the disease and that these numbers are set to rise.

    They have called for urgent investment to tackle the crisis in cancer services as people waiting on critical interventions for cancer have no time for any more delay.

    The Executive should be restored immediately and the additional £1 billion for health proposed by Finance Minister Conor Murphy should be used to tackle the waiting lists and the crises in cancer and mental health services.

    We need to recruit more doctors and nurses and give the health minister the resources to do this now.

    This is about treating patients who are suffering and saving lives.

    It’s well past time for the DUP to end their boycott of the Executive and get back to work for people who need it most.

  • Adam Afriyie – 2022 Comments on Vaping

    Adam Afriyie – 2022 Comments on Vaping

    The comments made by Adam Afriyie, the Conservative MP for Windsor, on 6 May 2022.

    Whilst I am a strong advocate for vaping as a means of harm reduction for adult smokers, it is clear that swift and decisive action should be taken against those pushing it on children.

  • Edward Argar – 2022 Statement on Lords Amendment 29B of the Health and Care Bill

    Edward Argar – 2022 Statement on Lords Amendment 29B of the Health and Care Bill

    The statement made by Edward Argar, the Minister for Health, in the House of Commons on 25 April 2022.

    The Lords amendments before the House today relate to the NHS workforce, reconfigurations, modern slavery and the adult social care cap. In respect of amendments 30B and 108B on reconfigurations, I am grateful for the constructive debate on these issue across both Houses. This House has twice voted strongly in favour of the ability for the Secretary of State to call in reconfiguration proposals when needed, and it remains a key principle that decisions on how services are delivered should be subject to ministerial oversight. However, my right hon. Friend the Secretary of State and I have listened carefully to the debates throughout the Bill’s passage, and as a result we have proposed a series of amendments to minimise bureaucracy and ensure transparency.

    The first set of changes would mean that the NHS had to notify the Secretary of State only about those reconfiguration proposals that were deemed notifiable, which we will define through regulations. We intend to align that definition with the existing duty on NHS commissioners to consult local authorities where there is a substantial development of variation in the health service. We also propose to remove the requirement for commissioners and providers to inform Ministers of

    “circumstances that are likely to result in the need for the reconfiguration of NHS services”.

    Taken together, these changes will mean that the NHS will need to notify the Secretary of State only about proposals that are substantive and of great importance to people.

    Secondly, we will give local authorities, NHS commissioners and anyone else the Secretary of State considers appropriate a right to make representations to the Secretary of State when he has called in a proposal for reconsideration. We expect this to include any relevant provider. The Secretary of State will be required to publish a summary of the representations he receives, and we will set out in statutory guidance further detail on how local bodies, including providers, will be engaged.

    Thirdly, transparency is vital to ensure that these powers are always used by Ministers in the clear interest of the people we all serve. We will therefore require the Secretary of State to provide the reasons for his decisions and directions when he makes them. Finally, we have heard throughout these debates that it is vital that decisions are made expeditiously and expediently in order to give certainty to local bodies so that reconfigurations can be made quickly to improve the quality of services received by patients. We are therefore introducing a requirement that, once a reconfiguration proposal has been called in, the Secretary of State must make any decisions within six months. We believe that this set of changes addresses the key concerns raised in this House and the other place, and I commend it to the House.

    I turn to Lords amendment 48B, and the Government’s amendment in lieu, on modern slavery. We share the strength of feeling expressed in both Houses on ensuring that the NHS is in no way inadvertently linked with modern slavery and human trafficking through its supply chain. That is why the Government brought forward an amendment in the first round of ping-pong to create a duty on the Secretary of State to undertake a thorough review of NHS supply chains. I am pleased to announce today that we are going further. The Government’s amendment in lieu of Lords amendment 48B will require the Secretary of State to make regulations with a view to eradicating the use by the NHS in England of goods or services tainted by slavery or human trafficking. The regulations can set out steps the NHS should be taking to assess the level of risk associated with individual suppliers, and the basis on which the NHS should exclude them from a tendering process.

    I particularly commend my right hon. Friend the Member for Chingford and Woodford Green (Sir Iain Duncan Smith) for his consistent and vocal campaigning on this issue. I am delighted that he has confirmed his support for the amendment in lieu. I look forward to working further with him and his supporters to bring these measures forward.

    Ms Nusrat Ghani (Wealden) (Con)

    I congratulate the Minister and the Department on taking this extraordinary step. The public may believe that we already do not use slave-made goods, but unfortunately we do. It is remarkable that the Department has taken this step, and it is incredibly important that we look at Xinjiang in particular, where Sir Geoffrey Nice QC determined there has been a genocide, as there was in Bosnia. The sanctioned MPs and all our colleagues in the inter-parliamentary alliance on China will work with the Department to ensure we have no Uyghur slave-made products in our NHS.

    Edward Argar

    I paid tribute to my right hon. Friend the Member for Chingford and Woodford Green, but my hon. Friend the Member for Wealden (Ms Ghani) has also taken a keen interest in this issue. The Secretary of State and I will continue to work closely with others across Government to ensure that our measures to eradicate modern slavery in NHS supply chains are effective and targeted, and reflect best practice.

    On Lords amendment 29B, the Government are committed to improving workforce planning and are already taking the steps needed to ensure that we have record numbers of staff working in the NHS. In July 2021, the Department commissioned Health Education England to work with partners on reviewing the long-term strategic trends for the health and regulated social care workforce over the next 15 years. We anticipate the publication of that work in the coming weeks.

    Jim Shannon (Strangford) (DUP)

    Will the Minister give way?

    Edward Argar

    Very briefly, as I am conscious that we have limited time.

    Jim Shannon

    If the right hon. Member for South West Surrey (Jeremy Hunt) were to pursue the matter, my party and I would be minded to support him. Although I understand from the figures in the press today that there are significant numbers of new nurses coming into the NHS, there is still a large shortfall. Will the Minister confirm for Hansard in the Chamber today that every step is being taken to recruit the nurses needed to address the issue of workforce safety?

    Edward Argar

    The hon. Gentleman is right to highlight the work we are already doing, which I will address in a moment, and the number of nurses we have recruited. I believe we have now recruited 29,000 or so en route to our target of 50,000 more nurses by the end of this Parliament.

    Sir Robert Neill (Bromley and Chislehurst) (Con)

    Will my hon. Friend give way?

    Edward Argar

    I will make a little progress, if I may—a few more paragraphs—as I am very conscious of allowing time for Back-Bench colleagues to speak.

    Building on this work, we recently commissioned NHS England to develop a workforce strategy. We will set out the key conclusions of that work in due course. In addition, we have committed ourselves to merging Health Education England with NHS England to bring together responsibility for service, financial and workforce planning in one organisation. We will continue to grow and invest in the workforce. There are record numbers of staff, including nurses, working in the NHS.

    Sir Robert Neill

    I am grateful to the Minister for giving way. He will know of my interest as chair of the all-party parliamentary group on stroke, and he will be aware of the particular concern of the Stroke Association and others about the number of qualified therapists to provide the therapy people need after a stroke. Will he commit himself to that being part of the workforce strategy and to moving swiftly? This is already a pressing problem for stroke survivors who are not getting the care they need.

    Edward Argar

    I reassure my hon. Friend that my right hon. Friend the Secretary of State has made it clear that he wishes the whole health and care workforce landscape to be considered by Health Education England.

    The growth in our workforce comes on the back of our record investment in the NHS, which is helping to deliver our manifesto commitments, as I said to the hon. Member for Strangford (Jim Shannon), including our commitment to 50,000 more nurses by the end of the Parliament. The spending review settlement will also underpin funding for the biggest ever intake of undergraduate medical students and nurses.

    Although I might not be able to say anything sufficient to fully convince my right hon. Friend the Member for South West Surrey (Jeremy Hunt), I put on record my gratitude to him not only for the insight, expertise and knowledge he has brought to our debates on this issue but for the typical courtesy he has displayed throughout our interactions and conversations. I do not know what he will say in a moment, but I have tried to pre-empt him. I hope that he may be tempted to stick with it.

    I hope that the House will recognise that the Government are already doing substantial work to improve workforce planning, and that placing a requirement such as Lords amendment 29B on the statute book is therefore unnecessary.

    Kim Leadbeater (Batley and Spen) (Lab)

    Will the Minister give way?

    Edward Argar

    Very briefly, but I am sensitive to Madam Deputy Speaker’s instruction to be brief.

    Kim Leadbeater

    I thank the Minister for giving way. More than 100 organisations, including the Royal College of General Practitioners and the British Medical Association, have expressed their support for Lords amendment 29B. Does he agree that the only way to ensure that we recruit and retain the talented staff that our NHS and social care sector desperately need is through a long-term workforce plan in consultation with the experts in the field, such as health and care employers, unions and integrated care boards?

    Edward Argar

    That is exactly what we are doing through the work commissioned by my right hon. Friend the Secretary of State, which is why Lords amendment 29B is unnecessary.

    Steve Brine (Winchester) (Con)

    Will the Minister give way?

    Edward Argar

    I fear that I cannot, but my hon. Friend may catch me during my winding-up speech. I want to make progress, as about 10 Back-Bench colleagues wish to speak.

    Finally, on the adult social care cap, the Government have announced our plan for a sustainable social care system. It is fair, affordable and designed to end the pain of unpredictable care costs by capping the amount anyone needs to pay at £86,000. Without clause 140 there would be a fundamental unfairness: two people living in different parts of the country, contributing the same amount, would progress towards the cap at different rates based on differences in the amount their local authority is paying. We are committed to levelling up and must ensure that people in different parts of the country are benefiting to the same extent, and our provisions support this. Amendments 80A to 80N also make crucial changes to support the operation of charging reform, as these changes were lost by the removal of clause 140 in the other place.

    Lords amendments 80P and 80Q insert a regulation-making power to amend how

    “costs accrued in meeting eligible needs”

    is determined in section 15 of the Care Act 2014. However, if regulations were made using this power, they would result in anyone entering the care system under the age of 40 receiving free personal care up to that age. As local authority contributions would count towards the cap under these changes, a 35-year-old with average care costs would reach the cap and not have to pay anything towards the cost of their care, yet a person who enters care the day after their 40th birthday would need to contribute towards the £86,000 cap over their lifetime. We believe this is unfair. Our plan already includes a more generous means test that means more people will be eligible for state support towards the cost of care earlier, enabling them to keep more of their income.

    The changes introduced in the other place also threaten the affordability of our reforms. Lords amendments 80, 80P and 80Q would clearly affect financial arrangements to be made by this House and, as such, have financial privilege. These new Lords amendments would cost the taxpayer more than £1 billion a year by 2027-28. Ultimately, this would mean we need to make the same level of savings elsewhere, making the system less generous for other users. I hope I have been able to provide some reassurance that we believe our approach is still the right one, and I ask the House to disagree with the other place’s amendments.

    Finally, I put on record my gratitude to my hon. Friend the Member for Aberconwy (Robin Millar) and the noble Baroness Morgan of Cotes for their constructive and positive engagement during the Bill’s passage on ways to strengthen co-operation between the UK Government, the UK Statistics Authority, the Office for National Statistics and the devolved Administrations, and for their passion for strengthening the Union. I am pleased we are taking forward that work, albeit outside this Bill. I am stimulated by their important work.

    We have sought throughout the passage of the Bill to be pragmatic and to listen to this House and the other place in either accepting their amendments or addressing them in lieu. I hope the House recognises that this approach continues to characterise our work, save where we sadly cannot agree with the other place in respect of its amendments on both the workforce and social care caps.

  • Kit Malthouse – 2022 Comments on Improving Drug Treatment in Deprived Areas

    Kit Malthouse – 2022 Comments on Improving Drug Treatment in Deprived Areas

    The comments made by Kit Malthouse, the Combating Drugs Minister, on 13 April 2022.

    Aside from the personal misery and degradation, drugs are behind almost half of all burglaries and robberies, and drive violence and murder in too many neighbourhoods.

    We must maintain focus on the Prime Minister’s overall aim to reduce crime that blights our cities and towns, and the best way to do this is to work together to reduce homelessness, drug use and drug deaths. We will build on our work in the current Project ADDER locations, adding yet more heft to existing sites to accelerate the turnaround for addicts and their neighbours.